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Abstract Bone is a richly vascularized connective tissue.As
the main source of oxygen, nutrients, hormones, neuro-
transmitters and growth factors delivered to the bone cells,
vasculature is indispensable for appropriate bone develop-
ment, regeneration and remodeling. Bone vasculature also
orchestrates the process of hematopoiesis. Blood supply to
the skeletal system is provided by the networks of arteries
and arterioles, having distinct molecular characteristics and
localizations within the bone structures. Blood vessels of the
bone develop through the process of angiogenesis, taking
place through different, bone-specific mechanisms.
Impaired functioning of the bone blood vessels may be
associatedwith the occurrence of some skeletal and systemic
diseases, i.e., osteonecrosis, osteoporosis, atherosclerosis or
diabetes mellitus. When a disease or trauma-related large
bone defects appear, bone grafting or bone tissue engineer-
ing-based strategies are required. However, a successful
bone regeneration in both approaches largely depends on a
proper blood supply. In this paper, we review themost recent
data on the functions, molecular characteristics and signifi-
cance of the bone blood vessels, with a particular emphasis
on the role of angiogenesis and blood vessel functioning in
bone development and regeneration, as well as the conse-
quences of its impairment in the course of different skeletal
and systemic diseases.
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Vasculature of the bone: the role in skeleton
development, remodeling and regeneration
Bone is a highly vascularized connective tissue. Skeletal
vasculature plays a significant role in the process of bone
development (endochondral and intramembranous ossifi-
cation), regeneration and remodeling [1–3]. The skeletal
system receives between 10 and 15% of total cardiac out-
put [4]. Not only do blood vessels supply the skeletal
system with oxygen or nutrients and remove metabolites
from the bone, they also provide the skeleton with specific
hormones, growth factors and neurotransmitters secreted
by other tissues (e.g., brain-derived serotonin, [5]), main-
taining the bone cells survival and stimulating their activity
[6].
The significance of appropriate interactions between the
blood vessels and bone cells is well illustrated by different
abnormalities, leading to development of some skeletal
diseases, e.g., craniofacial dysmorphology [7, 8] or idio-
pathic osteonecrosis [9]. Both diseases result from inap-
propriate angiogenesis either during development of the
skeleton or an abnormal vascular system functioning
within the mature bones.
Bones containing osteoblasts which terminally differ-
entiate into osteocytes develop from a mesenchymal stem
cell precursor which can undergo osteogenesis through two
distinct mechanisms [10]. Endochondral ossification (with
cartilage as an intermediate stage) is typical for the long
bones, e.g., femur or tibia, whereas intramembranous
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ossification (related to a direct differentiation of mes-
enchymal stem cells into osteoblasts) is the main mecha-
nism leading to a development of flat (e.g., craniofacial)
bones [11]. In both modes of osteogenesis, angiogenesis,
associated with the production of vascular endothelial
growth factor (VEGF) by either hypertrophic chondrocytes
or differentiating mesenchymal cells, constitutes a critical
stage [12] (Fig. 1).
Secretion of VEGF is essential for coupling of osteo-
genesis and angiogenesis. VEGF (particularly VEGF-A)
acts as a chemotactic molecule, attracting endothelial cells
toward a bone tissue and directly controlling differentiation
and functions of osteoblasts and osteoclasts, participating
in the bone remodeling [13]. As shown by Maes et al. [14],
two main isoforms of the mouse VEGF-A, namely
VEGF164 and VEGF188 (equivalents of the human
VEGF165 and VEGF189 [15]) determine a proper bone
formation through the endochondral ossification. A com-
plete loss of both of these isoforms leads to an impaired
bone vascularization, growth plate morphogenesis and
disturbed endochondral ossification.
This is specifically caused by an impaired differentiation
and activity of the hypertrophic chondrocytes, but also
osteoblasts, endothelial cells and osteoclasts, critical for
bone formation and functioning. Maes et al. [16] also found
that among the two mouse-specific isoforms of the VEGF-
A: VEGF164 and VEGF188, only VEGF164 expressed alone
can compensate the loss of the VEGF188 isoform, without
any detrimental effects on proper bone development. On
the other hand, VEGF188 isoform expressed alone is
insufficient to properly direct the proliferation and survival
of chondrocytes under hypoxic conditions, indispensable
for an establishment of the epiphyseal vascularization
during endochondral bone formation.
In another paper, Maes et al. [17] showed that in mice
VEGF164 activates the PI3K/AKT pathway in osteoblasts
and induces a stabilization and signal transduction by the
main component of the Wnt signaling pathway, b-catenin.
Fig. 1 The stages of blood vessel invasion during endochondral a and intramembraneous b ossification. VEGF vascular endothelial growth
factor, POC Primary Ossification Center, SOC Secondary Ossification Center. Based on [12, 20]
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Overexpression of VEGF164 isoform leads to osteosclero-
sis, highly increased bone formation, accompanied by an
intensified osteoblast differentiation resulting in bone
overgrowth and altered bone morphology. This indicates a
need for a tight angiogenesis control during bone devel-
opment. Similar data have recently been published by Ben
Shoham et al. [18]. Interestingly, recent data also point to
the role of other molecules secreted by bone blood vessel
endothelial cells, e.g., Noggin (for further details, see
Chapter 3).
During bone development by the endochondral ossifi-
cation, cartilage vascularization begins with the formation
of hairpin loops, projecting from the perichondrial vascular
network to the adjacent cartilage. Next, a capillary
glomerulus forms at the leading edge and the entire vas-
cular unit grows in length with a mushroom-like shape.
Following elongation, the vascular unit is accompanied by
a backward expansion of the capillary network, tightly
surrounding a pair of main vessels (arteriole and venule)
[19].
Blood vessel formation during intramembraneous ossi-
fication (Fig. 1) was first described for a frontal bone of a
chick embryo by Thompson et al. [20]. These authors
demonstrated that during a developmental period, the
capillaries of a small diameter move into the thin avascular
layer of loose mesenchyme, which surrounds the mes-
enchymal condensation center, where mesenchymal cells
secrete VEGF, attracting endothelial cells (Fig. 1). This
process takes place shortly before the initial ossification of
the frontal bone. Then, the small vessels invade the con-
densation center right at or nearby the site of initial ossi-
fication, at the supra-orbital ridge. Shortly afterward, bone,
which first undergoes mineralization, associates with an
extensive internal and external network of blood vessels.
Further cascade of vascular invasion and ossification con-
tinues as a front of bone expansion moves externally in all
directions. Osteoblasts further participating in bone min-
eralization, lay down at the vicinity of capillaries pos-
sessing a large diameter.
Blood vessels also play a central role in the process of
bone remodeling and regeneration. During cortical bone
remodeling, the cutting cone, built of osteoclasts, moves
forward and resorbs either a dead bone or a damaged/old
bone matrix. The cutting cone is followed by a blood
vessel, which delivers nutrients and growth factors for
osteoblasts to lay down new bone behind the cone [5].
However, a question remains whether these are osteoblasts
or any other types of bone-forming cells, directly following
the blood vessels in developing or regenerating/remodeled
bones. The report by Maes et al. [21] indicates the specific
involvement of the osterix-expressing osteoblast precur-
sors, accompanying the blood vessels during endochondral
bone development and regeneration. The authors revealed
that some of these precursors exhibit a perivascular local-
ization and directly associate with the invading blood
vessels, which confirms a strong relationship between
angiogenesis and osteogenesis, but also indicates that these
are not mature osteoblasts, directly following the bone-
invading blood vessels (for further details, see Chapter 3).
There are two basic mechanisms of blood vessel for-
mation: vasculogenesis (formation of a blood vessel from a
progenitor cell, angioblast or hemangioblast) [22] and
angiogenesis (new vasculature development from the pre-
existing blood vessels) [23]. Vasculogenesis is critical for
the proper development of a whole embryo and as such
indirectly leads to the establishment of the primary bone
vasculature, through angiogenesis [24], which may for
instance rely on the bone-endothelium specific Notch sig-
naling and Nogging secretion (for further details see
Chapter 3). Angiogenesis also occurs during bone regen-
eration [25].
The main source of different growth and differentiation
factors, primarily VEGF, which is indispensable for
angiogenesis within a developing or mature bone tissue is
hypertrophic chondrocytes, mesenchymal cells or the blood
vessel-localized endothelial cells [26]. However, a recent
study by Wiszniak et al. [27] shows that during a devel-
opment of the flat bones, cranial neural crest cells (NCCs)
and the NCC-derived cells may also constitute an essential
source of VEGF which supports the blood vessel growth in
the developing jaw. Mice lacking the production of VEGF
in NCC-derived tissue exhibit a mandibular hypoplasia.
Therefore, according to Wiszniak et al. [27], undisrupted
secretion of VEGF is critical for normal chondrocyte pro-
liferation and Meckel’s cartilage growth as well as for
further jaw extension. Bone cells themselves also are a
vital source of VEGF (for further details, see the
Chapter 3).
Vasculature of the bone: its organization
and involvement in the process of hematopoiesis
The presence of a blood vessel network within bone was
first discovered in the seventeenth century in the experi-
ments of van Leewenhoek, to be further confirmed and
extensively researched in the twentieth century by the
groups of Trueta et al. [28, 29], Brookes [30], Thompson
et al. [20], Skawina et al. [31–33] or Georgia et al. [34].
The experiments of Brookes showed that blood circulates
within the bone cortex in a centrifugal and not in a cen-
tripetal direction [30]. This means that blood flows inside
the cortical bone through the nutrient arteries in the marrow
cavity and is returned by the periosteal veins [35] (Fig. 2).
However, a centripetal flow can replace a centrifugal flow
as a result of trauma or metabolic disease [36].
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Studies of the bone-localized vasculature and
microvasculature possess significant clinical relevance,
particularly in the context of bone regeneration approaches
in facial surgery [38]. Previously, the bone vascular system
was analyzed mostly via India ink injections [37]. Cur-
rently, the macroscopic organization of the vascular net-
work within bones is additionally studied by means of
scanning electron microscopy (SEM) vessel corrosion-
casts or computed tomography methods [19, 38–40].
At the macroscopic level, the blood vessel network
supplying the long bones is composed of three main sys-
tems: (1) the central nutrient artery, (2) metaphyseal-epi-
physeal arteries, and (3) periosteal artery [41]. It is worth
mentioning that in the long bones, the central nutrient
artery supplies the entire medullar cavity and the 2/3 of the
outer cortical bone, whereas the periosteal arteries pene-
trate the other 1/3 of the outer cortical bone (Fig. 2).
At the microscopic level, blood vessels of the long
bones localize within the Haversian (central) and Volk-
mann’s (perforating) canals in compact bone and further
pass above the medullary cavity, through the trabeculae of
the spongy bone [42]. In both Haversian and Volkmann’s
canals, blood vessels are accompanied by nerves.
Other types of bones: flat or irregular are differently
supplied with vasculature. Flat bones, i.e., cranial bones,
are delivered with blood through the periosteal arteries
[43]. Mandible (an example of the irregular bone) is
supplied by three arteries: the lingual, facial and inferior
alveolar arteries. The first 2 arise directly from the external
carotid, a major artery [44].
The microvasculature of, e.g., the long and flat bones
possesses some distinct characteristics. For example, Pan-
narale et al. [45] analyzed the microvasculature in rat
parietal, scapula, and ileum bone by means of vascular
corrosion cast (vcc, a resin-cast preparation), using the
light and SEM microscopy. The authors observed that the
bone thickness strongly affects the pattern of the micro-
circulation in the flat bones and that it varies in the thick
and thin parts of all types of bones mentioned above. At the
sites thinner than 0.4 mm, only the periosteal and dural
networks exist. Larger vessels, which do not form a true
vascular network, connect the two sites of the bones in
these regions. In thicker sites, the organization of the
microvasculature is similar to that observed in the long
bones. There, distinct periosteal, cortical and bone marrow
networks exist. Moreover, depending on the bone type and
surroundings (dura mater, muscles etc.), outer networks
exhibit moderate changes in their characteristics. Several
types of vessels were recognized by comparing their dif-
ferent diameter, course and endothelial imprints. The
observations of Pannarale et al. may be explained by the
variable metabolic and blood flow-originating needs of
different bones and a great influence of the bone archi-
tecture itself on the formation of the blood vessel network.
Besides secreting different nutritional and signaling
factors, e.g., VEGF-A, blood vessels localized in the bone
marrow cavity orchestrate the process of hematopoiesis,
and provide the Hematopoietic Stem Cells (HSCs) with the
necessary niche. This has been extensively researched
particularly within the long bones, e.g. [46].
Although it is currently commonly accepted that HSCs
are localized at the vicinity of bone blood vessels (both
arteries and veins), a specific location of their niche has
been unclear so far [47, 48]. However, recently Acar et al.
[47] have performed the analyses of the mouse HSC niche
localization within the bone marrow of the long bones
(tibiae and femurs). They have found that approximately
85% of cells are placed within 10–30 lm of a sinusoidal
blood vessel. Most HSCs, both dividing (defined as Ki-
67(?)) and non-dividing (defined as Ki-67(-)), localize in
the perisinusoidal niches with Lepr(?)Cxcl12(high) cells
throughout the bone marrow and are not positioned at the
vicinity of the arterioles, transition zone vessels, or bone
surfaces. On the other hand, Kunisaki et al. [48] demon-
strated that quiescent HSCs associate specifically with the
small arterioles, very commonly distributed within the
endosteal bone marrow, whereas in a study by Kusumbe
et al. [49] HSCs were frequently detected near the type H
endothelium (for further details see Chapter 3) and arteri-
oles in the endosteal region. Itkin et al. [50] found that
Fig. 2 Vascular system supplying the long bones. Based on [30].
Arteries/arterioles are marked in red and veins/venules in blue
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distinct types of blood vessel with different permeability
properties regulate mammalian bone marrow stem cell
maintenance and leukocyte trafficking. Arterial blood
vessels of a lower permeability (containing the Sca-1-, VE-
cadherin- and nestin-positive cells) maintain haematopoi-
etic stem cells in a low reactive oxygen species (ROS)-
inactive state, whereas the sinusoids of a higher perme-
ability (VE-cadherin-positive) promote hematopoietic stem
and progenitor cells (HSPCs) activation and constitute the
niche for immature and mature leukocyte within the bone
marrow.
These results altogether suggest that the arteriolar niches
are responsible for maintaining HSC quiescence. A con-
tinuous interchange between the two niches provides a
balance in HSCs proliferation and quiescence, which, when
disrupted, can lead to a development of leukemia [48]. The
knowledge resulting from those studies may also be critical
for the elaboration of HSCs mobilization and transplanta-
tion protocols [50]. Furthermore, the studies described
above show that bone blood vessels, as the orchestrators of
hematopoiesis, play an important systemic role in main-
taining the body homeostasis.
The role of blood vessel endothelium specialization
during bone formation and regeneration:
significance of VEGF-A secretion by osteoblasts
Even though blood vessels are constituted of many types of
cells, the main secretory role in angiogenesis is assigned to
endothelial cells. The results of the studies by Kusumbe
et al. [51] and Ramasamy et al. [52] suggest that blood
vessels of the bone (namely the arterioles) are lined with a
distinct type of the specialized endothelial cells, permeable
to some growth factors that specifically stimulate differ-
entiation of the bone precursor cells.
The previously mentioned authors, Kusumbe et al. [51],
identified two types of endothelial cells in the blood vessels
of the bones- type H and L. These two types differ in terms
of the surface marker expression and the level of expres-
sion of HIF1-a (hypoxia-inducible factor 1 alpha), a tran-
scription factor stimulating the growth of new blood
vessels through angiogenesis. Type H vascular endothelial
cells express higher levels of HIF1-a and are localized in
the vicinity of the chondro–osseous junction. They also
exhibit an intense CD31/endomucin (CD31(hi)Emcn(hi))
expression. Type L endothelial cells are localized in the
sinusoidal vessels in the diaphysis and are characterized by
a low expression of CD31 and endomucin (CD31(lo))
[51, 53]. Contrary to type H, the number of type L
endothelial cells does not change over time, which was
demonstrated by Kusumbe et al. [51] in the experiments on
young and old mice. These studies indicated that the
number of type H endothelial cells is age-dependent and
critical to appropriate bone functioning [51].
Kusumbe et al. [51] also showed that the precursor cells
involved in bone regeneration interact mostly with the type
H endothelial cells. According to those authors, an age-
related loss of bone precursor cells documented in a murine
model is associated with a gradual decrease in the number
of type H endothelial cells. This might explain a dimin-
ished regeneration potential of the bone, observed in the
elderly. In turn, the findings published by Ramasamy et al.
[52] suggest that maturation of type H endothelial cells
involves the Notch signaling pathway, while a blockade of
the latter cascade results in an impairment of bone for-
mation in a murine model, its activation promotes osteo-
genesis. The authors have demonstrated that Notch
activation in ECs is required for the endothelial cell pro-
liferation and stimulation of Noggin production (Fig. 3).
Endothelial Notch pathway and Noggin regulate differen-
tiation of perivascular osteoprogenitor cells and through
this osteogenesis, as well as promote the chondrocyte
maturation and hypertrophy. This affects angiogenesis
through the expression of VEGF-A by the hypertrophic
chondrocytes. The results of these studies show that blood
vessels of the bone, although mostly similar in function to
the vascular network of other tissues, possess unique
characteristics relying on the Notch/Noggin signaling
which enable their specific interaction with the bone cells
[52]. Specialization of the bone blood vessel endothelium
described above was also observed in some bone tissue
engineering-based experiments (for further information,
see Chapter 5). For instance, recent studies by Eman et al.
[54] have shown that ectopic bone formation is coupled
with a specific type of peripheral blood-derived endothelial
progenitor cells (EPCs), the so-called early-outgrowth
EPC, which, based on 3D matrigel plugs, cooperate with
mesenchymal stem cells in bone tissue-engineered con-
struct development.
Interestingly, a recent report by Ben Shoham et al. [18]
indicates a new role of bone vasculature, showing that it
can serve as a guiding template for a deposition of the
mineralized bone matrix. Using a mouse model, Ben
Shoham et al. demonstrated that during the embryonic
development, endothelial cells localized within the bone
blood vessels lack a basement membrane. They are instead
covered by the osteoblast-secreted collagen type I and can
undergo a gradual mineralization, thus serving as a min-
eralization template.
As mentioned previously, endothelial cells are the most
important secretory cells, producing VEGF within the
blood vessels [55]. However, many reports also point to a
significant role of the bone cells themselves in the regu-
lation of bone resorption and formation through the
secretion of factors typical for blood vessel endothelium.
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For instance, the studies by Hu et al. [13] have demon-
strated that VEGF-A, produced not by endothelial cells but
particularly by osteoblasts, is indispensable for the onset of
bone regeneration in vivo. By using the mouse knockout
model of the osteoblast-specific VEGF-A, the authors
confirmed that this factor regulates bone defect regenera-
tion through endochondral and intramembranous ossifica-
tion and stimulates the resorptive activity of the
osteoclasts. They also observed the existence of optimal
concentrations of exogenous VEGF which enable the
coupling of angiogenesis and osteogenesis in intramem-
branous ossification-driven bone regeneration.
VEGF-A can be expressed under hypoxic conditions,
which stimulate accumulation of HIF-1a inside the osteo-
blasts [56]. A recent paper by Cui et al. [57] indicates a
molecular mechanism of hypoxia and HIF-1a involvement
in the endochondral bone development. The authors
revealed that OASIS (also called CREB3L1), an endo-
plasmic reticulum (ER)-resident transcription factor, is
upregulated in a time-dependent manner during hypoxia
and binds to HIF-1a through its basic leucine zipper (bZIP)
domain.
This promotes a transcription of hypoxia-inducible
genes, including VEGF-A under hypoxic conditions.
The authors also found that OASIS-related deficiency in
osteoblasts leads to the impairment of vessel formation in
bone tissue and consequently impairs the process of bone
development.
Dysfunction of bone blood vessels in skeletal
and systemic diseases
Blood vessels supplying bones can undergo significant
changes when affected by both skeletal and systemic dis-
eases (Table 1). Among the skeletal diseases, osteonecro-
sis, also referred to as avascular necrosis, seems to be
directly associated with the blood vessel supply impair-
ment [58]. Avascular necrosis of the femoral head (ANFH)
is a pathologic process resulting from the interruption of
blood supply to the femur, characterized by development of
ischemic injury, necrotic death of the osteocytes, the col-
lapse of articular surface and the eventual onset of
osteoarthritis [59, 60]. The onset of this disease may be
initiated by femoral neck fractures, hip dislocations,
smoking or alcohol abuse. Feng et al. [60] suggested that
femoral head necrosis may be associated with endothelial
progenitor cells (EPCs) biology impairment, i.e., low
number of those cells, their decreased capacity to migrate
and increased senescence. EPCs, first characterized by
Asahara et al. [61], represent a subpopulation of bone
marrow-derived endothelial progenitors which may sub-
stantially contribute to a new blood vessel formation by
promoting new bone growth through neovascularization,
[61, 62]. Thus, a change in the numbers and functions of
EPCs, accompanying the ANFH, may reflect its common
underlying etiology [60]. It also is suggested that avascular
necrosis stems from a damage of the endothelial cell
membrane, in some circumstances combined with an
increased susceptibility of an individual to the blood clot
formation. This causes an interruption of the blood flow
which finally leads to osteonecrosis [59].
Also, osteoporosis, especially related to the post-
menopausal period, is associated with some significant
changes within the bone blood vessels. It is commonly
accepted that postmenopausal osteoporosis is characterized
by a reduced number of sinusoidal and arterial capillaries
in the bone marrow, leading to a decreased bone perfusion
[64]. Zhao et al. hypothesized that the activation of the HIF
signaling pathway (as mentioned previously, the hypoxia-
and HIF-related pathway is involved in angiogenesis) in
mouse osteoblasts, through osteoblast-specific disruption of
the HIF-degrading protein, i.e., Von Hippel–Lindau (VHL)
(DVhl), may protect mice from the ovariectomy-induced
bone loss. Compared to control littermates, DVhl mice,
with the genetically enhanced HIF signaling in osteoblasts,
had significantly increased trabecular and cortical bone
volumes. The authors also observed an enhanced blood
vessel formation compared to the controls. In the latter,
ovariectomy significantly decreased bone mineral density,
Fig. 3 Molecular crosstalk between type H endothelial cells (Type H EC) and mesenchymal stem cells, leading to osteoblast maturation and
final bone formation. Based on [51]
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significantly affected the bone microarchitecture, i.e.,
caused a decrease in the bone volume/total volume ratio or
tibia thickness, measured by means of the micro-CT
method, and caused a decrease in mechanical strength
compared to the control group (sham operated mice).
Significant decrease in the blood vessel volume and
expression of angiogenesis-related HIF-1a, HIF-2a, and
VEGF proteins at the distal femur in ovariectomized con-
trol mice were also noted. No such effects were observed in
DVhl mice. These results suggest that activation of the HIF
signaling pathway in osteoblasts may protect from estrogen
deficiency-induced bone loss and bone marrow-localized
decrease in blood vessels. Also Liu et al. [65], using a rat
model of ovariectomy, demonstrated that increased bone
vascularity and angiogenesis in the bone marrow might
protect from the bone loss, associated with the cessation of
estrogen production.
Besides the skeleton-associated diseases, systemic dis-
eases also negatively affect bone vasculature. Bone blood
supply may be compromised, e.g., in type 2 diabetes
mellitus (T2DM). It is commonly known that T2DM leads
to the development of microangiopathy [66]. Recently,
Stabley et al. [67] performed the studies on Zucker diabetic
fatty (ZDF) rats, a model of T2DM, and have shown that
progression of this disease causes vasoconstriction and
impairs the blood flow within the long bones. The authors
suggested that a decreased blood vessel supply, especially
within bone marrow, may further lead to osteopenia, usu-
ally observed in chronically T2DM-affected long bones.
The results of Oikawa et al. [68] suggest similar changes
within the bone marrow-localized blood vessels in type 1
diabetes mellitus (T1DM). Recently, Peng et al. [69]
characterized bone microstructure, strength, and the course
of bone turnover in a study performed on streptozotocin
(STZ)-induced diabetic mice (T1D mice). The authors also
explored the role of angiogenesis in the pathogenesis of
T1D-induced osteoporosis. The study revealed a decreased
angiogenesis (i.e., reduced number of blood vessels in the
femur and decreased expression of platelet endothelial cell
adhesion molecule (CD31), NGF-nerve growth factor, the
previously mentioned HIF-1a and VEGF) in type 1 dia-
betic mice compared to their healthy counterparts. Peng
et al. [69] concluded that the impairment of angiogenesis is
the main cause of a decreased bone formation and imbal-
anced remodeling, observed in diabetes. A report recently
published by Portal-Nu´n˜ez et al. [70] indicates an impor-
tant role of aging in worsening the bone-related compli-
cations associated with diabetes mellitus. In this study,
Portal-Nu´n˜ez and co-workers used male CD-1 mice,
2 month-old (young control group) or 16 month-old (old
animals). The authors analyzed two groups of mice: non-
diabetic and diabetic (streptozotocin-induced), within both
age groups (young vs. old). Portal-Nu´n˜ez et al. observed
that DM resulted in a decrease in some bone-related
parameters, e.g., the bone volume, trabecular number as
well as caused a diminished mineral apposition and bone
formation rates. They also observed significant bone
structure changes, with the increased trabecular separation
within L1-L3 vertebrae of aged mice. Tibias of the old
diabetic mice also exhibited changes in the three-point
bending tests, indicating their increased frailty and brit-
tleness. DM-suffering old mice also had a decreased
Table 1 The effects of the skeletal and systemic diseases on bone vasculature functioning
Skeletal or systemic disease The effects of a disease on bone vasculature and bone functioning in humans or laboratory animals
Avascular necrosis of the femoral
head (ANFH)
Decreased neovascularization caused by low number of endothelial progenitor cells (EPCs), their
diminished capacity to migrate and increased senescence in humans [56]
Blood flow interruption caused by damage of the endothelial cell membrane, in some circumstances
combined with an increased susceptibility of an individual to blood clot formation [55]
Ischemic injury, necrotic death of the osteocytes, the collapse of articular surface and the eventual onset of
osteoarthritis [55, 56]
Postmenopausal osteoporosis Decrease in blood vessel volume and expression of angiogenesis-related HIF-1a, HIF-2a, and VEGF
proteins in ovariectomized mice, suggesting that estrogen deficiency-induced bone loss is accompanied
by a decrease in number of bone marrow-localized blood vessels [60]
Diabetes mellitus Microangiopathy accompanying DM causes vasoconstriction and impairs blood flow within the long
bones of ZDF rats [63]
Decreased blood vessel supply, especially within bone marrow, may further lead to osteopenia, usually
observed in chronic T2DM-affected long bones [63]
Advanced glycation end products (AGEs), produced in diabetes mellitus, may also disrupt bone
vasculature [68]
Atherosclerosis Oxidized lipids produced during atherosclerotic plaque formation within bone blood vessels negatively
affect bone mass by increasing anti-osteoblastogenic inflammatory cytokines and decreasing pro-
osteoblastogenic Wnt ligands in ApoE-knockout, high-fat-diet-fed mice [70]
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expression of both VEGF and its type 2 receptor, which
were accompanied by an impaired femoral vasculature.
The authors also observed an increased expression of the
pro-adipogenic gene peroxisome proliferator-activated
receptor gamma (PPAR-c) and increased adipocyte number
in the bones of elderly mice. The levels and activity of the
reactive oxygen species-scavenging enzymes, e.g., glu-
tathione, remained unchanged in the old diabetic mice,
with the levels of xanthine oxidase slightly increased in the
bone marrow of those same mice. This may indicate that
intensive adipogenesis, replaces osteogenesis within the
bone marrow of the old mice. However, Portal-Nu´n˜ez and
co-workers [70] also noted an elevated expression of the
senescence-associated marker—caveolin-1 and p-53—in
the old, diabetic mice. Based on these results, the authors
concluded that the bone-related complications accompa-
nying DM are intensified during aging, and these effects
are strongly associated with an imbalanced bone turnover,
decreased vasculature parameters, and increased senes-
cence marker expression, but seem to be independent of the
anti-oxidative system or the Wnt signaling pathway in the
bone cells.
The studies by Bandeira et al. [71] suggested a link
between the iliac artery calcification and osteoporosis in
type 2 diabetic male patients. The authors examined 59
diabetic men aged 50–80 years, examined using bone
densitometry DXA (dual-energy X-ray absorptiometry)
method. The conclusion from this study was that there is a
significant association of osteoporosis in the lumbar spine
L1-L4 (p = 0.004) and in the femoral neck (p = 0.036)
with the iliac artery calcification, but the authors did not
explore any molecular mechanisms related to this phe-
nomenon. However, Bandeira et al. [71] suggest that it may
probably be associated with the elevated levels of osteo-
protegerin as well as receptor activator of Nfjb ligand
(RANK-L), usually extensively produced in diabetes mel-
litus by either immune cells or endothelial cells. This
seems to confirm a strong relationship between bone
metabolism, inflammatory status and a condition of bone
vasculature. Some studies suggest a significant role of the
advanced glycation end products (AGEs), produced in
diabetes mellitus, in the pathophysiology of atherosclerosis
(a metabolic disease affecting blood vessels, see the para-
graph below) and their direct link with diabetes-related
osteoporosis [72].
It is also currently believed that there exists a link
between osteoporosis and non-diabetic atherosclerosis. The
results of Prasad et al. [73] have indicated this association
in a study performed on 194 postmenopausal osteoporosis-
affected women. The authors have shown that the coronary
microvascular endothelial dysfunction (CMED) is an
independent predictor of osteoporosis in women aged more
than 50 years. Recently, Liu et al. [74] have found a link
between bone loss and atherosclerosis-resulting inflam-
mation in ApoE-knockout mice. The authors showed that
the osteoblast number and function were dramatically
reduced in trabecular and cortical bone of the ApoE-
knockout, high-fat-diet-fed (HFD) mice, a mouse model of
atherosclerosis [75]. At the same time, the osteoclast
number did not change in trabecular bone only. Conse-
quently, the authors observed a decreased number of
osteoblast progenitors and increased number of mono-
cyte/macrophages in the bone marrow as well as increased
expression of the proinflammatory cytokines IL-1b, IL-6,
and TNF. High-fat diet also impaired the Wnt signaling, by
inhibiting the expression of the Wnt-targeted genes and
downregulated the expression of the pro-osteoblastogenic
Wnt ligands. These results suggest that the oxidized lipids
produced during atherosclerotic plaque formation probably
also within bone blood vessels negatively affect bone mass
by increasing anti-osteoblastogenic inflammatory cytokines
and decreasing the pro-osteoblastogenic Wnt ligands.
This knowledge may potentially contribute to the elab-
oration of new strategies targeting blood vessels localized
within bone, which directly affect proper functioning of the
skeletal system and also the whole body.
Angiogenesis-targeted bone tissue engineering
or gene therapy in bone regeneration
Not only is the existence of vascular network indispensable
for a proper bone formation, but it is also crucial for its
functional restoration in a disease or trauma-suffering
patients. It is believed that the presence of blood vessels
within the autologous bone grafts is critical for a successful
bone regeneration, e.g., in the course of femoral head
osteonecrosis therapy or post-oncological bone recon-
struction [76, 77]. Although bone grafting serves as a gold
standard in bone defect treatment, its application is limited
[78] and thus forces elaboration of some new, alternative
strategies, e.g., based on bone tissue engineering. On the
other hand, appropriate bone-regenerating constructs
strongly rely on a successful vascularization [79]. Proper
blood supply is especially important in case of functional
bone constructs, possessing a clinically relevant size,
which leads to greater demands for oxygen and nutrients
compared to small bioimplants [80]. Blood vessel supply
within the tissue-engineered implants may positively
influence the process of constructs’ osseointegration and
bone defect restoration [81]. Recent studies point to a
significant role of vascularization techniques in bone tissue
engineering. For instance, the group of Weigand et al. [82]
hypothesized that extrinsic and intrinsic vascularization of
a large size bone tissue construct determines a successful
regeneration process within a bone defect. This study was
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carried out on sheep. The authors created microsurgically
an arteriovenous (AV) loop and connected it with the bone
substitute in either perforated titanium chambers (intrinsic/
extrinsic) for different time intervals of up to 18 weeks, or
tested the isolated Teflon() chambers (intrinsic) for
18 weeks (Fig. 4). A newly formed bone tissue was
observed as early as 12 weeks post-implantation within the
bioimplants vascularized by means of the intrinsic/extrinsic
method. In the intrinsic vascularization model, degradation
of the scaffold and osteoclastic activity was significantly
lower after 18 weeks, compared to the combined intrinsic–
extrinsic model, where degradation and osteoclast resorp-
tive activity was observed as early as 12 weeks post-im-
plantation. An increase in bone tissue formation after
18 weeks confirmed with the immunohistochemical stain-
ing for collagen type I, alkaline phosphatase and osteo-
calcin, was comparable for both the intrinsic/extrinsic and
intrinsic vascularization models.
Modern strategies of bone defect regeneration can also
be based on gene therapy, targeting different molecular
signaling pathways involved in both angiogenesis and
osteogenesis.
For example, Zhang et al. [83], demonstrated that
adeno-associated viral vectors carrying the sequences
encoding VEGF-A-the main factor involved in angiogen-
esis and BMP-7, which participates in osteogenesis can
effectively enhance healing of the femoral head in a rabbit
model of early, steroid-induced avascular necrosis of the
femoral head (SANFH). A combination of those two
sequences in one vector was more effective compared to a
separate expression of either VEGF-A or BMP-7. Appli-
cation of a gene therapy-based approach in the treatment of
the femoral head necrosis has also been tested by Cao et al.
[84]. These authors used deproteinized bone (DPB),
absorbed with recombinant plasmid pcDNA3.1-
hVEGF165, carrying the sequence coding for VEGF-A.
This DPB-VEGF compound was further implanted into the
drilled tunnel of a necrotic femoral head in rabbits.
Cao et al. also assessed the effects of DPB alone and
compared its performance to the control group, i.e., a
tunnel drilled in the necrotic femoral heads, left untreated.
The authors concluded that a transfection of hVEGF165
gene promotes local angiogenesis and that a combination
of DPB with VEGF improves the repair of the necrotic
femoral head. Therefore, a combination of DBP and
pcDNA3.1-hVEGF165 may become a potential, alternative
method for the treatment of osteonecrosis.
Summary
Blood vessels supplying bones orchestrate the process of
bone development and remodeling as well as regulate the
skeleton regeneration by delivering the nutrients, oxygen,
Fig. 4 Effects of the intrinsic/extrinsic (a) and intrinsic (b) vascularization modes on in vivo bone formation and remodeling by the bone
substitutes composed of Teflon chambers. Based on [82]
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hormones or growth factors to the bone cells. Blood vessels
localized in the bone marrow cavity of the long bones also
coordinate the process of hematopoiesis and provide the
niches occupied by the precursors of blood cells.
Recent findings point to a regulatory role and molecular
crosstalk between bone-related endothelium and osteo-
blasts, which play a significant role in bone development
and regeneration. These processes are regulated mainly
through the secretion of VEGF, the most important factor
of angiogenesis. Mutual communication between the bone
cells and endothelium is especially vital for a proper course
of osteogenesis. In this context, skeletal blood vessels were
shown to be lined with highly specialized endothelial cells.
The association between the proliferation and differen-
tiation of bone precursors and the activity of type H
endothelial cells, secreting Noggin has been particularly
well documented. Also, a new role of bone blood vessel
endothelium during bone mineralization has been recently
revealed. This knowledge may have some relevant clinical
implications for the treatment of bone regeneration disor-
ders or bone loss, e.g., in older people, often suffering from
osteoporosis or avascular osteonecrosis. However, it is
currently believed that bone blood vessels may also be
impaired by different systemic diseases: diabetes mellitus
or atherosclerosis—which, by affecting a whole body,
influence the health of the skeletal system. Both skeletal
and systemic diseases may result from either a disturbance
of a general blood vessel network or of the bone-specific
vasculature itself. Aging also negatively affects bone vas-
culature, and these effects seem to be intensified in sys-
temic diseases.
Not only is proper vascularization indispensable for
bone formation or remodeling, it is a key factor in devel-
opment of the in- and ex vivo bone regeneration strategies,
e.g., based on tissue engineering. Thus, the knowledge and
capability to target the molecular mechanisms underlying
bone blood vessel functioning may deliver us with some
new strategies to treat the vasculature-dependant skeletal
and systemic diseases which negatively affect the bone
metabolism.
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